Menu
Menu
The Spring 2024 Research Development Program (RDP) has closed. Thank you to those who expressed interest and applied to this funding call. Our next step will be to conduct reviews. Once these are completed, we will follow up with applicants. If you have any questions, please email crismatlantic@gmail.com and reference ‘RDP inquiry’ in the subject line.
This page provides general information about the Research development Program. We are pleased to share outcomes from the CRISM Atlantic 2023 Research Development Program HERE.
The CRISM Atlantic node aims to provide a dynamic research environment where clinicians, researchers, persons with lived experience, knowledge users and public health stakeholders converge to discuss and act on priorities in substance use research. The node is committed to supporting the development and implementation of funded protocols that are relevant, innovative and have the potential to accelerate the transfer of scientific knowledge in intervention and best practices in the management of substance use.
The Research Development Program aims to support CRISM Atlantic node members in the development of research projects and protocols that seek to:
Foster collaborations within the node, nationally, and internationally
Although this funding opportunity/competition attracts CRISM Atlantic Node members with experience in the competitive research grant application environment, we strongly encourage node members with less experience to seek collaboration opportunities with CRISM Atlantic Researchers to submit eligible protocols and projects to the RDP for review.
Applicants are invited to submit a concept sheet proposal to obtain financial support in order to:
A maximum of $10,000 can be awarded to an emerging project proposal (category 1 or 2). A maximum of $15,000 can be awarded to a promising project proposal (category 3). The number of awards will depend on funds available.
For details see RDP 2023 Awards
Principal Applicant: Dr. Bilikis Banire, Department of Psychiatry, Dalhousie University;
Co-Applicants:
Dr. Sandra Meier, Department of Psychiatry, Dalhousie University;
Dr. Sherry Stewart, Department of Psychiatry, Dalhousie University;
Nicholas Murray, Department of Psychiatry, Dalhousie University;
Dr. Rita Orji, Department of Computer Science, Dalhousie University
Principal Applicant: Dr. Cindy Feng, Department of Community Health and Epidemiology, Dalhousie University
Co-Applicant: Dr. Mark Asbridge, Department of Community Health and Epidemiology, Dalhousie University
Principal Applicant: Dr. Candice Crocker, Department of Psychiatry, Dalhousie University
Co-Applicant: Dr. Phil Tibbo, Department of Psychiatry, Dalhousie University
Principal Applicant: Laura Beach, PhD Candidate, University of Toronto and Coordinator, East Coast Prison Justice Society Visiting Committee
Co-Applicants:
Dr. Leah Genge, Department of Family Medicine, Dalhousie University;
Becky Marval, OT. Reg. (N.S.), Mobile Outreach Street Health and Dalhousie School of Occupational Therapy
Principal Applicant: Nicole Peters-Vuozzo, Health PEI, Mental Health and Addictions
Co-Applicants :
Dr. Jaqueline Goodwin, Health PEI, Mental Health and Addictions
Dr. Jo-Ann Birt, Health PEI, Mental Health and Addictions
Sex Differences and Menstrual Phase Fluctuations in Cannabis-Related Psychiatric Emergency Department Presentations
Dr. Amanda Hudson (Dalhousie University, NS)
Developing an Innu First Nations evaluation framework for implementing a community-wide FASD prevention strategy in two communities
Dr. Melody E. Morton Ninomiya (Wilfrid Laurier University, NFL/ON)
Drinking to cope with interpersonal conflict as a pathway to problem drinking in women: Does romantic relationship conflict matter most?
Dr. Sherry Stewart (Dalhousie University, NS)
Exploring cannabis harm reduction strategies for women through community-based participatory research
Dr. Stephen Ellenbogen (Memorial University of Newfoundland, NFL)
Exploration of Therapies for Opioid Use Problems in a First Nation in Nova Scotia
Dr. Dennis Wendt, Department of Educational and Counselling Psychology (McGill University)
Treatment of Depression in Individuals with Opiod Use Disorder: A Randomized Placebo-Controlled Trial
Dr Didier Jutras-Aswad (Université de Montréal, Qc)
Substance Use Cessation Therapies for those At-Risk in Early Intervention Services for Psychosis: Research Protocol Development
Dr Phil Tibbo (Dalhousie University, NS)
Opioid Use following Opiod Prescription for Non-Specific Low Back Pain in Nova Scotian Emergency Departments
Dr Jill Hayden (Dalhousie University, NS)
Suivi de la cohorte bas seuil en traitement de la dépendance aux opioïdes RELAIS du programme CRAN
Marie-Ève Goyer (University of Montreal, QC)
Evaluating the effectiveness of prescription monitoring programs to reduce inappropriate opioid prescribing and related-harms: A feasibility study
Mark Asbridge (Dalhousie University, NS)
Mon buzz
Mathieu Goyette and Dr. Jorge Flores-Aranda (University of Sherbrooke, QC)
Scaling up access to personality-targeted interventions for youth at risk of substance use disorders in the United States and Canada: A hybrid effectiveness-implementation facilitation trial.
Patricia Conrod (University of Montreal QC) and Dr. Sherry Stewart (Dalhousie University, NS)
A Phase II randomized, double-blind, placebo-controlled multicenter study of Desvenlafaxine for depression in patient with opioid dependence (DESV TRIAL)
Dr. Didier Jutras-Aswad (University of Montreal, QC)
crismatlantic@gmail.com
Dalhousie University
1355 Oxford St., P.O. Box 15000
Halifax, Nova Scotia B3H 4R2